Rockwell Medical Announces European Patent Issuance for Proprietary SFP Formulation

Rockwell Medical

announced today that it has received notice from the European Patent Office that it has obtained patent issuance on its proprietary GMP formulation for Soluble Ferric Pyrophosphate (SFP), the Company's lead investigational drug that provides iron replacement to hemodialysis patients with CKD.